SEOM clinical guidelines in early-stage breast cancer 2015

被引:15
作者
Garcia-Saenz, J. A. [1 ]
Bermejo, B. [2 ]
Estevez, L. G. [3 ]
Palomo, A. G. [4 ]
Gonzalez-Farre, X. [5 ]
Margeli, M. [6 ]
Pernas, S. [7 ]
Servitja, S. [8 ]
Rodriguez, C. A. [9 ]
Ciruelos, E. [10 ]
机构
[1] Hosp Clin San Carlos, Madrid, Spain
[2] Hosp Clin Univ, Valencia, Spain
[3] CIOCC Hosp Univ Madrid Sanchinarro, Madrid, Spain
[4] Complejo Asistencial Univ Leon, Leon, Spain
[5] Hosp Univ Quiron Dexeus, Barcelona, Spain
[6] Hosp Univ Germans Trias I Pujol Badalona ICO Bada, Barcelona, Spain
[7] Hosp Duran I Reynals ICO, Barcelona, Spain
[8] Hosp del Mar, Barcelona, Spain
[9] Hosp Univ Salamanca IBSAL, Salamanca, Spain
[10] Hosp Univ 12 Octubre, Madrid, Spain
关键词
Early-stage breast cancer; Clinical guidelines; Adjuvant; Neoadjuvant; Genomic platforms; 20-YEAR FOLLOW-UP; NEOADJUVANT CHEMOTHERAPY; ADJUVANT TRASTUZUMAB; DISTANT RECURRENCE; OPEN-LABEL; POSTMENOPAUSAL PATIENTS; GENE-EXPRESSION; PAM50; RISK; TAMOXIFEN; WOMEN;
D O I
10.1007/s12094-015-1427-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a major public health problem. Despite remarkable advances in early diagnosis and treatment, one in three women may have metastases since diagnosis. Better understanding of prognostic and predictive factors allows us to select the most appropriate adjuvant therapy in each patient. In these guidelines, we summarize current evidence for the medical management of early-stage breast cancer.
引用
收藏
页码:939 / 945
页数:7
相关论文
共 55 条
[51]   Outcomes by Tumor Subtype and Treatment Pattern in Women With Small, Node-Negative Breast Cancer: A Multi-Institutional Study [J].
Vaz-Luis, Ines ;
Ottesen, Rebecca A. ;
Hughes, Melissa E. ;
Mamet, Rizvan ;
Burstein, Harold J. ;
Edge, Stephen B. ;
Gonzalez-Angulo, Ana M. ;
Moy, Beverly ;
Rugo, Hope S. ;
Theriault, Richard L. ;
Weeks, Jane C. ;
Winer, Eric P. ;
Lin, Nancy U. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (20) :2142-+
[52]   Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer [J].
Veronesi, U ;
Cascinelli, N ;
Mariani, L ;
Greco, M ;
Saccozzi, R ;
Luini, A ;
Aguilar, M ;
Marubini, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) :1227-1232
[53]   Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial [J].
von Minckwitz, Gunter ;
Schneeweiss, Andreas ;
Loibl, Sibylle ;
Salat, Christoph ;
Denkert, Carsten ;
Rezai, Mahdi ;
Blohmer, Jens U. ;
Jackisch, Christian ;
Paepke, Stefan ;
Gerber, Bernd ;
Zahm, Dirk M. ;
Kummel, Sherko ;
Eidtmann, Holger ;
Klare, Peter ;
Huober, Jens ;
Costa, Serban ;
Tesch, Hans ;
Hanusch, Claus ;
Hilfrich, Joern ;
Khandan, Fariba ;
Fasching, Peter A. ;
Sinn, Bruno V. ;
Engels, Knut ;
Mehta, Keyur ;
Nekljudova, Valentina ;
Untch, Michael .
LANCET ONCOLOGY, 2014, 15 (07) :747-756
[54]   Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials [J].
von Minckwitz, Gunter ;
Untch, Michael ;
Nueesch, Eveline ;
Loibl, Sibylle ;
Kaufmann, Manfred ;
Kuemmel, Sherko ;
Fasching, Peter A. ;
Eiermann, Wolfgang ;
Blohmer, Jens-Uwe ;
Costa, Serban Dan ;
Mehta, Keyur ;
Hilfrich, Joern ;
Jackisch, Christian ;
Gerber, Bernd ;
du Bois, Andreas ;
Huober, Jens ;
Hanusch, Claus ;
Konecny, Gottfried ;
Fett, Werner ;
Stickeler, Elmar ;
Harbeck, Nadia ;
Mueller, Volkmar ;
Jueni, Peter .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) :145-156
[55]   Recurrence score and quantitative ER expression to predict in late distant recurrence risk in ER+ BC after 5 years of tamoxifen. [J].
Wolmark, Norman ;
Mamounas, Eleftherios P. ;
Baehner, Frederick L. ;
Butler, Steven M. ;
Tang, Gong ;
Jamshidian, Farid ;
Sing, Amy P. ;
Shak, Steven ;
Paik, Soonmyung .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)